Merck & Co., Inc.

Merck & Co., Inc.

Merck & Co., Inc.

Overview
Date Founded

1891

Headquarters

2000 Galloping Hill Road, Kenilworth, NJ, 07033, USA

Type of Company

Public

Employees (Worldwide)

69K

Industries

Pharmaceuticals
Medical Support Services
Wholesale: Consumer Non-Durables/Sundries
Hospitals & Patient Services
Biotechnology

Company Description

Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.

Contact Data
Trying to get in touch with decision makers at Merck & Co., Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Executive Officer

Chief Executive Officer

Executive Vice President, Global Services & Chief Financial Officer

Executive Vice President, Chief Marketing Officer

Executive Vice President, Chief Commercial Officer

Chief Compliance Officer

Chief Medical Officer

Executive Vice President & President, Consumer Care

Senior Vice President, Finance, Global Controller & Principal Accounting Officer

Managing Director-BioPharma Business, China

Board of Directors

Chief Executive Officer at Merck & Co., Inc.

Chief Executive Officer at Corning, Inc.

Executive Chairman at 3M Interamerica, Inc.

Chairman & Chief Executive Officer at SARR Group LLC

Former Managing Partner of Global Business Operations at Accenture Plc

Executive Chairman & Founder at BlueVoyant LLC

Former Chief Executive Officer at Nokia of America Corp.

Founder & Advisor at Sierra Ventures

Director at BioFrontiers Institute

President-Marketing Solutions at Google, Inc.

Paths to Merck & Co., Inc.
Potential Connections via
Relationship Science
You
Merck & Co., Inc.
Owners & Shareholders
Details Hidden

The Vanguard Group is an American investment management company based in Malvern, Pennsylvania, that manages approximately $3.4 trillion[1] in assets. It is the largest provider of mutual funds and now the second-largest provider of exchange-traded funds (ETFs) in the world after BlackRock, with about $451 billion in ETF assets under management, as of March 2015.[3] It offers mutual funds and other financial products and services to retail and institutional investors in the United States and abroad. Founder and former chairman John C. Bogle is credited with the creation of the first index fund available to individual investors,[4] the popularization of index funds generally,[5] and driving costs down across the mutual fund industry.

Details Hidden

SSgA FM's methods of analysis include quantitative, fundamental, technical, cyclical, indexing, arbitrage, charting and other strategy specific methods. They offer a broad range of strategies including: Active, Enhanced, and Passive Equity; Active & Passive Debt; Cash Management; Multi-Asset Class Solutions; Real Estate (including Direct Real Estate); Senior Loans; Managed Futures; and Private Equity. Active equity strategies include enhanced equity and active quantitative strategies. The strategies cover market-cap and style segments of the market including: large-cap core, large-cap growth, large-cap value, mid-cap, small-cap, small-cap value, all-cap, and long-short equity. They also manage long-short and long-short market neutral strategies. SSgA FM's Active & Passive Debt strategies offers a range of investment styles from passive to active, short to long duration, tax-exempt, sovereign to high yield, and single country to global. The firm's Cash Management strategies seek to generate current income while preserving capital and liquidity by investing in diversified portfolios of short-term securities. SSgA FM's Multi-Asset Class strategies employ an asset allocation model as means of diversification and seek to position assets among major investment categories. Their Multi Asset Class Solutions strategies employ an asset allocation model as a method of diversification that aims to position assets among major investment categories. SSgA FM's Managed Futures strategy allocates assets using two approaches: a managed futures strategy and a fixed income strategy. The firm's Private Equity strategies focus on rigorous partner selection, thorough evaluation of quality investment opportunities, and fundamental, research-driven research.

Details Hidden

CWI employs a long-term, value-oriented global investment approach and a multiple portfolio manager system that combines teamwork and individual accountability. The firm is committed to maintaining low operating expenses, among the lowest in the fund industry. They utilize fundamental research to gather in-depth information on markets and companies around the world. CWI employs a security-by-security approach to portfolio construction and emphasize long-term investments. Their strategies focus on determining the difference between the fundamental value of a company and its price in the marketplace. CWI offers a wide variety of equity, fixed-income and balanced investment strategies. Their strategies are categorized as global, multi-regional and regional investment strategies.

Recent Transactions
Details Hidden

Merck & Co., Inc. purchases Tilos Therapeutics, Inc. from ShangPharma Innovation, Inc., Boehringer Ingelheim Venture, Partners Innovation Management Co. LLC

Details Hidden

Merck & Co., Inc. purchases Peloton Therapeutics, Inc. from Topspin Management LLC, Nextech Invest AG, OrbiMed Advisors Private Equity, Remeditex Ventures LLC, The Column Group LLC, Tichenor Ventures LLC

Details Hidden

Merck Sharp & Dohme Corp., Merck & Co., Inc. purchase Immune Design Corp.

Transaction Advisors
Legal Advisor

Advised onMerck & Co., Inc. purchases Schering-Plough Corporation

Accountant

Advised onMerck & Co., Inc. purchases Rosetta Inpharmatics LLC

Legal Advisor

Advised onMerck & Co., Inc. purchases Schering-Plough Corporation

Legal Advisor

Advised onMerck & Co., Inc. purchases Schering-Plough Corporation

Legal Advisor

Advised onMerck & Co., Inc. purchases Schering-Plough Corporation

Legal Advisor

Advised onMerck & Co., Inc. purchases Schering-Plough Corporation

Advisors & Consultants
Legal Advisor

Senior Vice President, General Counsel & Secretary at General Electric Company

Advisor

Chairman & Chief Executive Officer at MDC Partners, Inc.

Legal Advisor

Partner at Jones Day

Clients

Covetrus, Inc. engages in developing technologies and services for animal health industry. It also provides products, software, and services to help drive improved patient health, strong client relationships, and successful financial outcomes for veterinary professionals. The company was founded on April 13, 2018 and is headquartered in Melville, NY.

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

JG Summit Holdings, Inc. is one of the leading companies in the Philippines with business interests in: Air Transportation, Banking, Food Manufacturing, Petrochemicals, Real Estate, Hotels & Property Development, and Telecommunications.

Co-Founder at Caribou Biosciences, Inc.

Key Stats and Financials As of 2018
Market Capitalization
$212B
Total Enterprise Value
$221B
Earnings Per Share
$2.32
Revenue
$42.4B
Net Profit
$6.22B
EBITDA
$14.3B
EBITDAMargin
33.67%
Total Debt
$25.1B
Total Equity
$26.9B
Enterprise Value Sales
5.21x
Enterprise Value EBITDAOperating
15.47x
TEVNet Income
35.55x
Debt TEV
0.11x
Three Year Compounded Annual Growth Rate Of Revenue
3.06%
Five Year Compounded Annual Growth Rate Of Revenue
-0.76%
Non-Profit Donations & Grants
$1M +
2017
$5,000 +
2017
Political Donations
$1,000
2014
$1,000
2014
$500
2014
Investments
Details Hidden

Just Biotherapeutics, Inc. operates as biotechnology firm. Its products include biosimilars and novel and repositioned biologics. The firm also offers molecular design, process and product platform and manufacturing and plant design services. The company was founded by James N. Thomas, Victor P. Fung, Dean K. Pettit, and Yining Zhao in 2014 and is headquartered in Seattle, WA.

Details Hidden

Themis Bioscience GmbH operates as a biotechnology company, which engages in the development of prophylactic vaccinations from preclinical to early clinical phase. The firm focuses on the prevention of tropical infectious diseases. Its proprietary Themaxyn technology platform, in-licensed from Paris-based Institute Pasteur, forms the basis of all of the company's vaccine candidates. The company was founded on September 1, 2009 by Erich Tauber and is headquartered in Vienna, Austria.

Details Hidden

Sutro Biopharma Inc. engages in the drug discovery, development and manufacturing of pharmaceutical products. Its products technologies include XpressCF, anti-body drug conjugates, bispecifics & engineered antibodies and cGMP facility. The company was founded by James R. Swartz and Sutanto Widjaja in June 2003 and is headquartered in South San Francisco, CA.

Investors
Details Hidden

Investor at Avid Radiopharmaceuticals, Inc.

Details Hidden
Details Hidden

Co-Founder at SCR Engineers Ltd.

Suppliers
Codexis, Inc. Chemicals | Redwood City, CA

Codexis, Inc. engages in the discovery, development, and sale of proteins. The company offers enzyme optimization services and developing biocatalyst products. The firm operates through the following segments: Performance Enzymes and Novel Biotherapeutics. Its technologies accelerate the development of manufacturing processes for active pharmaceutical ingredients fine chemicals, agrochemicals, food ingredients, detergents and biofuels. The company was founded in January 2002 and is headquartered in Redwood City, CA.

Johnson & Johnson Pharmaceuticals | New Brunswick, New Jersey

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Bayer AG Medical Support Services | Leverkusen, NW

Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials. As an innovation company, it sets trends in research-intensive areas. Bayer’s products and services are designed to benefit people and improve the quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and acts as a socially and ethically responsible corporate citizen. In fiscal year 2012, Bayer employed 110,500 people and had sales of €39.8 billion. Capital expenditures amounted to €2 billion, R&D expenses to €3 billion.

Competitors
Johnson & Johnson Pharmaceuticals - New Brunswick, New Jersey

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Amgen, Inc. Biotechnology - Thousand Oaks, CA

Amgen, Inc. is a biotechnology medicines company, which discovers, develops, manufactures and markets medicines for grievous illnesses. The company focuses on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology. It markets recombinant protein therapeutics in supportive cancer care, nephrology and inflammation. The company's products include Neulasta, a pegylated protein, based on the Filgrastim molecule and NEUPOGEN, a recombinant-methionyl human granulocyte colony stimulating factor both of which selectively stimulate the production of neutrophils; Enbrel, an inhibitor of tumor necrosis factor, a substance that plays a role in the body's response to inflammatory diseases; Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin receptor agonist that mimics endogenous TPO, the primary driver of platelet production. Amgen was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Biogen, Inc. Biotechnology - San Diego, CA

Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. It offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA, and FAMPYRA for the treatment of multiple sclerosis; SPINRAZA for the treatment of spinal muscular atrophy; and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.

Awards & Honors
Rank #72
2016
Fortune Magazine - Fortune 1000 Companies
Sponsored by Fortune Magazine
Rank #72
2016
Fortune Magazine - Fortune 500 Companies
Sponsored by Fortune Magazine
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Merck & Co., Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Merck & Co., Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Merck & Co., Inc..